Loading
A phase 3 trial of tislelizumab, paclitaxel / nab-paclitaxel, cisplatin and carboplatin in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting.
SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04） is a phase 3, randomised interventional study registered as NCT07633873 by CSPC Megalith Biopharmaceutical Co.,Ltd., with a registry enrolment figure of 500 participants, started 2026-06-02 and due to reach its primary completion in 2027-09-30. Interventions recorded: SYS6010 injection; Enlonstobart injection; Tislelizumab injection; Paclitaxel+Carboplatin or Pemetrexed + Cisplatin/Carboplatin. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: Progression Free Survival (PFS) assessed by IRC. Lung eligibility wording from the registry: "Participants with pathologically confirmed locally advanced or metastatic NSCLC". No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Platinum agents, Cisplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Cisplatin and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Platinum agents, Cisplatin and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Platinum agents, Cisplatin and the tag lung-deep-dive.
Shares Tislelizumab, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Carboplatin and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/